In this study, we have found through in silico analysis that the TGFβ signaling pathway is the most dysregulated pathway in glioblastoma, and ZEB2 is involved in this pathway mostly through interactions with SMAD2 and SMAD5. Here, SMAD2 is linked to glioblastoma.